webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

m-PEG5-Ms

  CAS No.: 130955-38-3   Cat No.: BADC-00921   Purity: ≥98% 4.5  

m-PEG5-Ms is a mesylated monofunctional PEG linker used in ADC construction to facilitate nucleophilic substitution. The PEG5 spacer boosts solubility and stability of conjugates, making it suitable for drug-linker modification and enhancing targeted therapeutic delivery.

m-PEG5-Ms

Structure of 130955-38-3

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C12H26O8S
Molecular Weight
330.40
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
2,5,8,11,14-pentaoxahexadecan-16-yl methanesulfonate
IUPAC Name
2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethyl methanesulfonate
Canonical SMILES
COCCOCCOCCOCCOCCOS(=O)(=O)C
InChI
InChI=1S/C12H26O8S/c1-15-3-4-16-5-6-17-7-8-18-9-10-19-11-12-20-21(2,13)14/h3-12H2,1-2H3
InChIKey
GIZXGFFADYUCPD-UHFFFAOYSA-N
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.

m-PEG5-Ms, also known as methoxy polyethylene glycol mesylate, is a reagent commonly used in bioconjugation and polymer modification. Here are some key applications of m-PEG5-Ms:

Protein Modification: m-PEG5-Ms is frequently used to PEGylate proteins, which involves attaching polyethylene glycol (PEG) to enhance their stability and solubility. This modification can reduce immunogenicity and extend the half-life of therapeutic proteins in the bloodstream. As a result, PEGylated proteins often show improved pharmacokinetic properties and therapeutic efficacy.

Drug Delivery Systems: m-PEG5-Ms is utilized in the design of drug delivery vehicles due to its ability to increase the hydrophilicity and biocompatibility of drug carriers. By conjugating PEG to drugs or drug-loaded nanoparticles, researchers can achieve controlled and sustained release profiles. This is particularly valuable for enhancing the targeting and circulation time of therapeutic agents in the body.

Surface Coating: In biomedical device manufacturing, m-PEG5-Ms is employed as a surface coating agent to minimize protein adsorption and cell adhesion. This property is critical for devices like implants and sensors, which require inert surfaces to avoid unwanted biological interactions. PEGylation helps maintain the device’s functionality and reduces fouling in vivo.

Polymer Science: m-PEG5-Ms serves as a key intermediate in the synthesis of various functional polymers with tailored properties. It can be used to introduce mesylate groups into polymer backbones, which then facilitate further chemical modifications or crosslinking reactions. This versatility enables the creation of custom materials for applications ranging from hydrogels to responsive coatings.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Bis-PEG6-NHS ester | Bis-PEG17-NHS ester | Mal-PEG2-NHS ester | Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 | PNU159682-EDA | PNU-159682 carboxylic acid | DMEA-PNU-159682 | MC-VC-PAB-DMEA-PNU159682 | m-PEG7-Ms | Bis-PEG10-NHS ester | m-PEG5-Ms
Send Inquiry
Verification code
Inquiry Basket